NCT02816021 2026-04-06
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
Phase 2 Completed
M.D. Anderson Cancer Center
University of California, San Diego
Celgene
National Cancer Institute (NCI)